Indeed, positive effects were reported for the NLRP3 inhibitors hemin, which protected against CLP‐induced acute lung injury in mice,39 and scutellarin40 and glyburide,41 which improved survival of mice with bacterial sepsis. The gene discussed is NLRP3; the disease is bacterial infectious disease with sepsis.